TBPH
TheravanceยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TBPH Profile
Theravance Biopharma, Inc.
A biopharmaceutical company that developing small molecule medicines in the areas of infections, CNS/pain, respiratory disease
C/O Theravance Biopharma US, Inc., 901 Gateway Boulevard, South San Francisco, CA 94080
--
Theravance Biopharma, Inc., was registered as a Cayman Islands exempted company limited by shares in July 2013. The company is a biopharmaceutical company focused on drug discovery, development and commercialization. The company's core purpose is to create drugs that can change people's lives. The company used decades of expertise to develop the FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary disease.
